Patients with heart disease or diabetes were more likely than those without the conditions to remain on statin therapy, according to a study. Among patients without heart disease or diabetes, those who were most likely to continue taking statins were overweight/obese or former smokers. The researchers also found that heavy …

According to multiple presentations, IDegLira, the fixed combination of insulin degludec and liraglutide, showed long-term efficacy across a range of body mass indices and parameters for type 2 diabetes patients…. 

Consuming healthier foods improves risk independently of other lifestyle changes such as weight loss or physical activity…. 

Results from dulaglutide’s sixth AWARD trial showed once-weekly dulaglutide 1.5mg was non-inferior to once-daily liraglutide 1.8mg when compared to metformin…. 

A large database analysis has found that two oral diabetes drug classes, thiazolidinediones (TZDs) and sulfonylureas, both increase the risk for fractures when compared with metformin…. 

Diabetic patients who received bariatric surgery saw greater weight loss and fewer macrovascular and microvascular complications than those treated with usual care…. 

The United States has 3 million more diabetic patients today than in 2010…. 

The FDA recently approved tapentadol-ER (Nucynta ER) for the treatment of peripheral neuropathy in diabetics…. 

HNF1A is also the gene responsible for (maturity onset diabetes of the young type 3 (MODY3), a rare monogenic cause of diabetes….

Type 1 diabetes patients have better control of their blood sugar levels with an artificial pancreas….